Amneal Pharmaceuticals Inc Class A (AMRX)

Amneal Pharmaceuticals, Inc. is a common stock listing on NASDAQ tied to a global biopharmaceutical company focused on generics, injectables, biosimilars, and specialty branded medicines. Its operations are organized into three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment spans a broad set of dosage forms and delivery systems, including oral solids, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilars, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops and distributes products aimed at central nervous system and endocrine conditions, including Parkinson’s disease and hypothyroidism, with products such as Rytary, Unithroid, ONGENTYS, and CREXONT. AvKARE serves governmental and institutional customers with pharmaceuticals, medical and surgical products, and related distribution and packaging services. The company was founded in 2002, formerly operated as Atlas Holdings, Inc., and is headquartered in Bridgewater, New Jersey.

Jump directly to the stock analysis sections supported by the latest available data.